drugset
drugset / Trial / NCT02677493

Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.'

NCT02677493 ↗

Phase 3 Completed 1794 enrolled Il-Yang Pharm. Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates the immunogenicity and safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.' in healthy male and female adults at the age of 19 or older.

Timeline

Start
2015-10
Primary completion
2016-01
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator IL-YANG Flu Vaccine Prefilled Syringe Vaccine 0.5 ml Intramuscular
Subject IL-YANG Quadrivalent Influenza Vaccine Vaccine 0.5 ml Intramuscular
Comparator IL-YANG Trivalent Influenza Vaccine Vaccine 0.5 ml Intramuscular

Indications

influenza